🔎 Trials Near Me

Hem › Hypofarynxcancer › Oklahoma

Kliniska studier för Hypofarynxcancer i Oklahoma

4 studier för Hypofarynxcancer söker deltagare vid platser i Oklahoma.

Städer i Oklahoma

Officiell studietext (engelska)

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

  • Cancer Centers of Southwest Oklahoma Research, Lawton
  • University of Oklahoma Health Sciences Center, Oklahoma City
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT06589804

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

  • University of Oklahoma Health Sciences Center, Oklahoma City
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT05136196

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

  • University of Oklahoma Health Sciences Center, Oklahoma City
  • Mercy Hospital Oklahoma City, Oklahoma City
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 14 sep. 2026 · NCT02734537

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

  • University of Oklahoma Health Sciences Center, Oklahoma City
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 17 aug. 2026 · NCT06532279

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.